Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in Arch Bronconeumol Retrieve available abstracts of 61 articles: HTML format

Single Articles

May 2025
1. VAN DER MOLEN MC, Posthuma R, Vaes AW, Spruit MA, et al
   Metabolic Changes After Bronchoscopic Lung Volume Reduction With Endobronchial Valves in COPD Patients.
   Arch Bronconeumol. 2025;61:282-289.
   PubMed     Abstract available
   
   
   
2. CASAL-GUISANDE M, Represas-Represas C, Golpe R, Fernandez-Garcia A, et al
   Clinical and Social Characterization of Patients Hospitalized for COPD Exacerbation Using Machine Learning Tools.
   Arch Bronconeumol. 2025;61:264-273.
   PubMed     Abstract available
   
   
   
3. GOLPE R, Veiga I, Dacal-Rivas D, Blanco-Cid N, et al
   Blood Eosinophil Count During Severe Bronchiectasis Exacerbation and Risk of Hospital Readmission.
   Arch Bronconeumol. 2025 May 1:S0300-2896(25)00156.
   PubMed    
   
   
   April 2025
4. MAROTO E, Esteban Lombarte MDM, Garriga-Baraut T, Garcia Del Cerro G, et al
   Efficacy of a Digitally Supported Intervention for Children and Adolescents With Difficult-to-control Asthma (INSPIRINGKIDS): Results From a Multicentre Randomized Controlled Trial.
   Arch Bronconeumol. 2025 Apr 28:S0300-2896(25)00140.
   PubMed    
   
   
   
5. DACAL RIVAS D, Martinez-Moragon E, Plaza V, Cisneros Serrano C, et al
   Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study.
   Arch Bronconeumol. 2025 Apr 26:S0300-2896(25)00139.
   PubMed     Abstract available
   
   
   
6. MUNOZ-SANCHEZ B, Leon-Lloreda A, Romero-Falcon A, Medina-Gallardo JF, et al
   Identification of Fractional Exhaled Nitric Oxide Cutoff Values for the Diagnosis of Asthma.
   Arch Bronconeumol. 2025 Apr 2:S0300-2896(25)00121.
   PubMed    
   
   
   
7. OSCULLO G, Mendez R, Olveira C, Giron R, et al
   Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry.
   Arch Bronconeumol. 2025;61:196-202.
   PubMed     Abstract available
   
   
   March 2025
8. MARTIN-GONZALEZ E, Perez-Garcia J, Martin-Almeida M, Hernandez-Perez JM, et al
   Genome-wide Association Study of Asthma Exacerbations in the Spanish Population.
   Arch Bronconeumol. 2025 Mar 20:S0300-2896(25)00091.
   PubMed    
   
   
   
9. FERNANDEZ-BARAT L, Lopez-Aladid R, Alcaraz-Serrano V, Vazquez N, et al
   Clinical and Lung Microbiome Impact of Chronic Versus Intermittent Pseudomonas aeruginosa Infection in Bronchiectasis.
   Arch Bronconeumol. 2025 Mar 18:S0300-2896(25)00082.
   PubMed     Abstract available
   
   
   
10. JIN KN, Lee HJ, Park H, Lee JK, et al
    Mucus Plugs as Precursors to Exacerbation and Lung Function Decline in COPD Patients.
    Arch Bronconeumol. 2025;61:138-146.
    PubMed     Abstract available
    
    
    
11. BETANCOR D, Olaguibel JM, Del Pozo V, Alvarez Puebla MJ, et al
    FEV(1)Q as a Predictive Metric for Asthma Outcomes.
    Arch Bronconeumol. 2025 Mar 1:S0300-2896(25)00072.
    PubMed    
    
    
    February 2025
12. OSCULLO G, Bekki A, Olveira C, Giron R, et al
    Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis.
    Arch Bronconeumol. 2025 Feb 4:S0300-2896(25)00043.
    PubMed     Abstract available
    
    
    
13. BERNABEU-MORA R, Valera-Novella E, Bernabeu-Serrano ET, Soler-Cataluna JJ, et al
    Five-Repetition Sit-to-Stand Test as Predictor of Mortality in High Risk COPD Patients.
    Arch Bronconeumol. 2025;61:90-95.
    PubMed     Abstract available
    
    
    January 2025
14. OSCULLO G, Bekki A, Martinez-Garcia MA
    Microbiome, Metabolome and Complexity in Bronchiectasis: The Future is Here.
    Arch Bronconeumol. 2025 Jan 31:S0300-2896(25)00033.
    PubMed    
    
    
    
15. ZHANG XX, He ZF, He JH, Chen ZM, et al
    Sputum Microbiota Correlates With Metabolome and Clinical Outcomes in Asthma-Bronchiectasis Overlap.
    Arch Bronconeumol. 2025 Jan 6:S0300-2896(25)00006.
    PubMed     Abstract available
    
    
    
16. ROMERO FALCON MAA, Leon Lloreda A, Gomez-Bastero A
    Experience With the Use of Biological Therapy for Asthma Control During Pregnancy: Preliminary Results.
    Arch Bronconeumol. 2025 Jan 6:S0300-2896(25)00004.
    PubMed    
    
    
    
17. ERSOZ H, Torres-Duran M, Turner AM, Tanash H, et al
    Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry.
    Arch Bronconeumol. 2025;61:22-30.
    PubMed     Abstract available
    
    
    December 2024
18. CHEN X, Li D, Ma Z
    A Commentary on 'Effect of the Antibody-Mediated Immune Responses on COPD, Asthma, and Lung Function: A Mendelian Randomization Study'.
    Arch Bronconeumol. 2024 Dec 5:S0300-2896(24)00454.
    PubMed    
    
    
    
19. ALVARADO-MIRANDA M, Solano A, Marsico S, Nunez-Robainas A, et al
    Clinical Implications of Functional Imaging in the Assessment of Bronchiectasis-Associated Sarcopenia.
    Arch Bronconeumol. 2024 Dec 4:S0300-2896(24)00453.
    PubMed     Abstract available
    
    
    November 2024
20. ANSEDE-BORDONABA G, Giron-Moreno RM, Martinez-Vergara A
    Ulcerative Colitis, Bronchiectasis and Tofacitinib.
    Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00438.
    PubMed    
    
    
    October 2024
21. GUIXING X, Yilin L, Huaying F, Fanrong L, et al
    Effect of the Antibody-mediated Immune Responses on COPD, Asthma, and Lung Function: A Mendelian Randomization Study.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00406.
    PubMed     Abstract available
    
    
    
22. PADILLA-GALO A, Rubio-Moreno M, Valencia-Azcona B
    Asthma-COPD Overlap - A Gateway to Biological Treatment.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00409.
    PubMed    
    
    
    
23. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G
    Reply to Letter: The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Oct 9:S0300-2896(24)00377.
    PubMed    
    
    
    
24. SCHILFARTH P, Maurac A, Macey J, Decloedt C, et al
    Sleep Quality in Patients Receiving Long-term NIV: A Prospective Cohort Study.
    Arch Bronconeumol. 2024;60:652-655.
    PubMed    
    
    
    
25. PINERO-GUTIERREZ P, Villar-Alvarez F, Asensio-Mathews P, Gonzalez-Peinado D, et al
    Organizing Pneumonia Secondary to ASIA Syndrome.
    Arch Bronconeumol. 2024;60:658-659.
    PubMed    
    
    
    
26. JO YS, Rhee CK, Kim SH, Lee H, et al
    Spirometric Transition of at Risk Individuals and Risks for Progression to Chronic Obstructive Pulmonary Disease in General Population.
    Arch Bronconeumol. 2024;60:634-642.
    PubMed     Abstract available
    
    
    
27. KERGET B, Cinar I, Akdag BN, Yesilyurt M, et al
    New Indicators of Exercise Capacity and Respiratory Function in COPD Patients: The Role of Gastrocnemius Muscle Oxygenation and Elastography Levels.
    Arch Bronconeumol. 2024;60:643-645.
    PubMed    
    
    
    
28. KHO SS, Ing SK, Tie ST
    The Effect of Bronchoscopic Lung Volume Reduction on Hemidiaphragm Excursion.
    Arch Bronconeumol. 2024;60:668-669.
    PubMed    
    
    
    September 2024
29. PLAZA V, Garcia G, Perez de Llano L, Quirce S, et al
    Initiating Biological Treatment of Asthma: When is the Right Time?
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00364.
    PubMed    
    
    
    
30. TIOTIU CEPUC A, Steiropoulos P, Novakova S, Nedeva D, et al
    Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00367.
    PubMed     Abstract available
    
    
    
31. TRAVERSI L, Garriga-Grimau L, Moreno-Galdo A, Polverino E, et al
    The In-between: Time to Talk About Bronchiectasis in Adolescents and Their Transition to Adult Care.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00359.
    PubMed     Abstract available
    
    
    
32. BARREIRO E, Gea J
    Muscle Fatigability of Patients With Severe COPD and Chronic Respiratory Failure: The Contribution of Respiratory Factors.
    Arch Bronconeumol. 2024;60:543-544.
    PubMed    
    
    
    
33. MALLAH N, Urbieta AD, Rivero-Calle I, Gonzalez-Barcala FJ, et al
    New Vaccines for Chronic Respiratory Patients.
    Arch Bronconeumol. 2024;60:565-575.
    PubMed     Abstract available
    
    
    
34. VILLENEUVE T, Guilleminault L, Guibert N
    Sequential and Multimodal Bronchoscopic Interventions for COPD: Toward a Highly Personalized Interventional Pulmonology?
    Arch Bronconeumol. 2024;60:600-601.
    PubMed    
    
    
    August 2024
35. ALOBID I, Bernal-Sprekelsen M, Mullol J
    The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Aug 31:S0300-2896(24)00317.
    PubMed    
    
    
    
36. JACOME C, Jacome M, Correia S, Flores I, et al
    Effectiveness, Adherence and Safety of Home High Flow Nasal Cannula in Chronic Respiratory Disease and Respiratory Insufficiency: A Systematic Review.
    Arch Bronconeumol. 2024;60:490-502.
    PubMed     Abstract available
    
    
    July 2024
37. GIL-MARTINEZ M, Rodrigo-Munoz JM, Antonio Canas J, Sastre J, et al
    Sputum Proteome Reveals Differences Between Eosinophilic and Non-eosinophilic Asthma Phenotypes.
    Arch Bronconeumol. 2024 Jul 20:S0300-2896(24)00273.
    PubMed    
    
    
    
38. WU X, Deng Z, Wu F, Zheng Y, et al
    Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in China.
    Arch Bronconeumol. 2024;60:402-409.
    PubMed     Abstract available
    
    
    
39. AGUSTI A, Lopez-Campos JL, Miravitlles M, Soler-Cataluna JJ, et al
    Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial.
    Arch Bronconeumol. 2024;60:417-422.
    PubMed     Abstract available
    
    
    
40. PANERONI M, Cavicchia A, Beatrice S, Bertacchini L, et al
    The Influence of Lung Function and Respiratory Muscle Strength on Quadriceps Muscle Fatigability in COPD Patients Under Long-term Oxygen Therapy.
    Arch Bronconeumol. 2024;60:410-416.
    PubMed     Abstract available
    
    
    June 2024
41. COSIO BG, Shafiek H, Torrego A
    Bronchoscopy in Severe Asthmatics: Is it a Safe Procedure?
    Arch Bronconeumol. 2024 Jun 18:S0300-2896(24)00224.
    PubMed    
    
    
    
42. MA D, Munoz X, Ojanguren I, Romero-Mesones C, et al
    Increased TGFbeta1, VEGF and IFN-gamma in the Sputum of Severe Asthma Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Jun 7:S0300-2896(24)00221.
    PubMed     Abstract available
    
    
    
43. DE MIGUEL-DIEZ J, Gomez Doblas JJ
    Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Response to Additional Considerations.
    Arch Bronconeumol. 2024;60:392-393.
    PubMed    
    
    
    
44. GOLPE R, Figueira-Goncalves JM
    Comment on "Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease".
    Arch Bronconeumol. 2024;60:391.
    PubMed    
    
    
    
45. FERNANDEZ-VILLAR A, Cimas Hernando JE, Figueira Goncalves JM, De Miguel Diez J, et al
    Continuity of Care in Chronic Obstructive Pulmonary Disease Exacerbations: Challenges and Priorities.
    Arch Bronconeumol. 2024;60:327-329.
    PubMed    
    
    
    May 2024
46. GONZALEZ J, Seijo LM, de-Torres JP, Benitez ID, et al
    Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP.
    Arch Bronconeumol. 2024 May 16:S0300-2896(24)00170.
    PubMed     Abstract available
    
    
    
47. GARRIGA-GRIMAU L, Sanz-Santiago V, Moreno-Galdo A
    Implementation of the Spanish Paediatric Bronchiectasis Registry (Child-BEAR-es Registry).
    Arch Bronconeumol. 2024 May 6:S0300-2896(24)00143.
    PubMed    
    
    
    
48. FORCADA BARREDA C, Fuentes Gago MG, Gomez Hernandez MT
    Subconjunctival Emphysema After Videothoracoscopic Segmentectomy.
    Arch Bronconeumol. 2024 May 4:S0300-2896(24)00138.
    PubMed    
    
    
    
49. BALLESTEROS-REVIRIEGO G, Arbillaga-Etxarri A, Marti JD
    Inspiratory Muscle Training: Back to Basics Must be the First Step?
    Arch Bronconeumol. 2024;60:267-268.
    PubMed    
    
    
    
50. PAPI A, Alfano F, Bigoni T, Mancini L, et al
    N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
    Arch Bronconeumol. 2024;60:269-278.
    PubMed     Abstract available
    
    
    
51. CUENCA PERIS S, Martinez Tomas R, Briones Gomez A, Cases Viedma E, et al
    What to Do When Endobronchial Volume Reduction Treatment Fails.
    Arch Bronconeumol. 2024;60:319-320.
    PubMed    
    
    
    April 2024
52. CAKIR E, Ibis E, Yuzuak E
    Probable Invasive Aspergillosis Causing Massive Subcutaneous Emphysema by Rupturing the Pleura and Forming a Bronchopleural Fistula.
    Arch Bronconeumol. 2024 Apr 30:S0300-2896(24)00131.
    PubMed    
    
    
    
53. MASELLI DJ, Diaz AA
    Mortality Risk in Bronchiectasis.
    Arch Bronconeumol. 2024 Apr 24:S0300-2896(24)00114.
    PubMed    
    
    
    
54. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G, Blanco-Aparicio M, et al
    Spanish Consensus on Remission in Asthma (REMAS).
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00109.
    PubMed     Abstract available
    
    
    
55. PAN CX, He ZF, Lin SZ, Yue JQ, et al
    Clinical Characteristics and Outcomes of the Phenotypes of COPD-Bronchiectasis Association.
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00110.
    PubMed     Abstract available
    
    
    
56. MAKRINIOTI H, Zhu Z, Saglani S, Camargo CA, et al
    Infant Bronchiolitis Endotypes and the Risk of Developing Childhood Asthma: Lessons From Cohort Studies.
    Arch Bronconeumol. 2024;60:215-225.
    PubMed     Abstract available
    
    
    
57. DE MIGUEL-DIEZ J, Nunez Villota J, Santos Perez S, Manito Lorite N, et al
    Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.
    Arch Bronconeumol. 2024;60:226-237.
    PubMed     Abstract available
    
    
    March 2024
58. GAO YH, Zhu YN, Bai JW, Liang S, et al
    Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00073.
    PubMed    
    
    
    
59. CHANG AB, Dharmage SC, Marchant JM, McCallum GB, et al
    Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation.
    Arch Bronconeumol. 2024 Mar 10:S0300-2896(24)00062.
    PubMed     Abstract available
    
    
    
60. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
    Effect of Comorbidities and Gender Differences in Survival in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 2:S0300-2896(24)00055.
    PubMed    
    
    
    
61. VITACCA M, Malovini A, Paneroni M, Spanevello A, et al
    Predicting Response to In-Hospital Pulmonary Rehabilitation in Individuals Recovering From Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2024;60:153-160.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.